Vitamins group Homart brings in Ords, CLSA as it preps for ASX float

Copy link Copied Copy link Copied Subscribe to gift this article Gift 5 articles to anyone you choose each month when you subscribe. Already a subscriber? Login Homart Pharmaceuticals, a Sydney vitamins and beauty products business, is eyeing an ASX float next year as revenues approach $130 million and investors look for opportunities in the sector following the departure of industry giant Blackmores after a $1.9 billion buyout.

Homart manufactures and sells vitamins and supplements brands SpringLeaf, Top Life, Urvita and Health’N’Nature, and owns the Cheri anti-ageing beauty products brand. Copy link Copied Copy link Copied Subscribe to gift this article Gift 5 articles to anyone you choose each month when you subscribe. Already a subscriber? Login Introducing your Newsfeed Follow the topics, people and companies that matter to you.

Most Viewed In Companies.